The Journal of Allergy and Clinical Immunology
Volume 118, Issue 3 , Pages 682-690 , September 2006

Distribution and determinants of house dust mite allergens in Europe: The European Community Respiratory Health Survey II

  • Jan-Paul Zock, PhD

      Affiliations

    • From the Center for Research in Environmental Epidemiology, Municipal Institute of Medical Research, Barcelona
    • Corresponding Author InformationReprint requests: Jan-Paul Zock, PhD, IMIM, Dr Aiguader 80, E-08003 Barcelona, Spain.
  • ,
  • Joachim Heinrich, PhD

      Affiliations

    • National Research Center for Environment and Health, Institute of Epidemiology, Neuherberg
  • ,
  • Deborah Jarvis, MD

      Affiliations

    • Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, Imperial College, London
  • ,
  • Giuseppe Verlato, MD, PhD

      Affiliations

    • Department of Medicine and Public Health, University of Verona
  • ,
  • Dan Norbäck, PhD

      Affiliations

    • Department of Medical Science, Occupational and Environmental Medicine, Uppsala University
  • ,
  • Estel Plana, MSc

      Affiliations

    • From the Center for Research in Environmental Epidemiology, Municipal Institute of Medical Research, Barcelona
  • ,
  • Jordi Sunyer, MD, PhD

      Affiliations

    • From the Center for Research in Environmental Epidemiology, Municipal Institute of Medical Research, Barcelona
  • ,
  • Susan Chinn, DSc

      Affiliations

    • Department of Public Health Sciences, King's College London
  • ,
  • Mario Olivieri, MD

      Affiliations

    • Unit of Occupational Medicine, University of Verona
  • ,
  • Argo Soon, PhD

      Affiliations

    • Department of Public Health, University of Tartu
  • ,
  • Simona Villani, PhD

      Affiliations

    • Department of Health Sciences, Section of Epidemiology and Medical Statistics, University of Pavia
  • ,
  • Michela Ponzio, PhD

      Affiliations

    • Department of Health Sciences, Section of Epidemiology and Medical Statistics, University of Pavia
  • ,
  • Anna Dahlman-Hoglund, PhD

      Affiliations

    • Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Göteborg
  • ,
  • Cecilie Svanes, MD, PhD

      Affiliations

    • Department of Thoracic Medicine, Institute of Medicine, University of Bergen
  • ,
  • Christina Luczynska, PhD

      Affiliations

    • Department of Public Health Sciences, King's College London
    • Deceased.
  • ,
  • for the Indoor Working Group of the European Community Respiratory Health Survey II

Received 22 December 2005 ,Revised 7 April 2006 ,Accepted 10 April 2006.

References 

  1. Nelson HS. The importance of allergens in the development of asthma and the persistence of symptoms. J Allergy Clin Immunol. 2000;105:S628–S632
  2. Arlian LG, Morgan MS. Biology, ecology, and prevalence of dust mites. Immunol Allergy Clin North Am. 2003;23:443–468
  3. Arbes SJ, Cohn RD, Yin M, Muilenberg ML, Burge HA, Friedman W, et al. House dust mite allergen in US beds: results from the First National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol. 2003;111:408–414
  4. Lintner TJ, Brame KA. The effects of season, climate, and air-conditioning on the prevalence of Dermatophagoides mite allergens in household dust. J Allergy Clin Immunol. 1993;91:862–867
  5. Van Strien RT, Koopman LP, Kerkhof M, Oldenwening M, de Jongste JC, Gerritsen J, et al. Mattress encasings and mite allergen levels in the Prevention and Incidence of Asthma and Mite Allergy study. Clin Exp Allergy. 2003;33:490–495
  6. Macan J, Kanceljak B, Plavec D, Milkovic-Kraus S. Differences in mite fauna between the continental and Mediterranean climates of Croatia: microscopy and Dustscreen test findings. Allergy. 2003;58:780–783
  7. Sidenius KE, Hallas TE, Poulsen LK, Mosbech H. House dust mites and their allergens in Danish mattresses: results from a population based study. Ann Agric Environ Med. 2002;9:33–39
  8. Moscato G, Perfetti L, Galdi E, Pozzi V, Minoia C. Levels of house-dust-mite allergen in homes of nonallergic people in Pavia, Italy. Allergy. 2000;55:873–878
  9. Gross I, Heinrich J, Fahlbusch B, Jager L, Bischof W, Wichmann HE. Indoor determinants of Der p 1 and Der f 1 concentrations in house dust are different. Clin Exp Allergy. 2000;30:376–382
  10. Wickens K, de Bruyne J, Calvo M, Choon-Kook S, Jayaraj G, Lai CK, et al. The determinants of dust mite allergen and its relationship to the prevalence of symptoms of asthma in the Asia-Pacific region. Pediatr Allergy Immunol. 2004;15:55–61
  11. The European Community Respiratory Health Survey II Steering Committee . The European Community Respiratory Health Survey II. Eur Respir J. 2002;20:1071–1079
  12. Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J. 1994;7:954–960
  13. Zock JP, Jarvis D, Luczynska C, Sunyer J, Burney P. Housing characteristics, reported mold exposure, and asthma in the European Community Respiratory Health Survey. J Allergy Clin Immunol. 2002;110:285–292
  14. Melki IS, Beydoun HA, Khogali M, Tamim H, Yunis KA. Household crowding index: a correlate of socioeconomic status and inter-pregnancy spacing in an urban setting. J Epidemiol Commun Health. 2004;58:476–480
  15. Bleda Hernandez MJ, Tobias Garces A. Application of tobit regression models in modelling censored epidemiological variables. Gac Sanit. 2002;16:188–194
  16. Lubin JH, Colt JS, Camann D, Davis D, Cerhan JR, Severson RK, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect. 2004;112:1691–1696
  17. Gehring U, Brunekreef B, Fahlbusch B, Wichmann HE, Heinrich J, INGA Study Group . Are house dust mite allergen levels influenced by cold winter weather?. Allergy. 2005;60:1079–1082
  18. Brunekreef B, van Strien R, Pronk A, Oldenwening M, de Jongste JC, Wijga A, et al. La mano de DIOS… was the PIAMA intervention study intervened upon?. Allergy. 2005;60:1083–1086
  19. Van Strien RT, Gehring U, Belanger K, Triche E, Gent J, Bracken MB, et al. The influence of air conditioning, humidity, temperature and other household characteristics on mite allergen concentrations in the northeastern United States. Allergy. 2004;59:645–652
  20. El Sharif N, Douwes J, Hoet PH, Doekes G, Nemery B. Concentrations of domestic mite and pet allergens and endotoxin in Palestine. Allergy. 2004;59:623–631
  21. Recer GM. A review of the effects of impermeable bedding encasements on dust-mite allergen exposure and bronchial hyper-responsiveness in dust-mite-sensitized patients. Clin Exp Allergy. 2004;34:268–275
  22. O'Connor GT. Allergen avoidance in asthma: what do we do now?. J Allergy Clin Immunol. 2005;116:26–30
  23. Van Strien RT, Verhoeff AP, Brunekreef B, Van Wijnen JH. Mite antigen in house dust: relationship with different housing characteristics in The Netherlands. Clin Exp Allergy. 1994;24:843–853
  24. Simpson A, Woodcock A, Custovic A. Housing characteristics and mite allergen levels: to humidity and beyond. Clin Exp Allergy. 2001;31:803–805
  25. Schei MA, Hessen JO, Lund E. House-dust mites and mattresses. Allergy. 2002;57:538–542
  26. Mihrshahi S, Marks G, Vanlaar C, Tovey E, Peat J. Predictors of high house dust mite allergen concentrations in residential homes in Sydney. Allergy. 2002;57:137–142
  27. Warner A, Bostrom S, Munir AK, Moller C, Schou C, Kjellman NI. Environmental assessment of Dermatophagoides mite-allergen levels in Sweden should include Der m 1. Allergy. 1998;53:698–704
  28. Luczynska C, Sterne J, Bond J, Azima H, Burney P. Indoor factors associated with concentrations of house dust mite allergen, Der p 1, in a random sample of houses in Norwich, UK. Clin Exp Allergy. 1998;28:1201–1209
  29. Dharmage S, Bailey M, Raven J, Cheng A, Rolland J, Thien F, et al. Residential characteristics influence Der p 1 levels in homes in Melbourne, Australia. Clin Exp Allergy. 1999;29:461–469

 The coordination of ECRHS II was supported by the European Commission as part of their Quality of Life program. The following bodies funded the local studies in ECRHS II included in this article: Albacete: Fondo de Investigaciones Santarias (grant code: 97/0035-01, 99/0034-01, and 99/0034-02), Hospital Universitario de Albacete, Consejería de Sanidad; Antwerp: Fund for Scientific Research-Flanders Belgium (grant code: G.0402.00), University of Antwerp, Flemish Health Ministry; Barcelona: Spanish Respiratory Society (SEPAR), Public Health Service (grant code: R01 HL62633-01), Fondo de Investigaciones Santarias (grant code: 97/0035-01, 99/0034-01, and 99/0034-02), Interdepartmental Council of Technological Research and Innovation (CIRIT) (grant code: 1999SGR 00241), Red Respira Carlos III Health Institute; Basel: Swiss National Science Foundation, Swiss Federal Office for Education and Science, Swiss National Accident Insurance Fund, USC National Institute of Environmental Health Sciences Center grant 5P30 ES07048; Erfurt: GSF–National Research Center for Environment and Health, Deutsche Forschungsgemeinschaft (grant code FR 1526/1-1); Galdakao: Basque Health Department; Göteborg: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences and Allergy Research, Swedish Asthma and Allergy Foundation, Swedish Cancer and Allergy Foundation; Grenoble: Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 #2610, Ministry of Health, Direction de la Recherche Clinique, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Sante, CHU de Grenoble, Comite des Maladies Respiratoires de l'Isere; Hamburg: GSF–National Reasearch Center for Environment and Health, Deutsche Forschungsgemeinschaft (grant code MA 711/4-1); Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign); Huelva: Fondo de Investigaciones Santarias (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Oviedo: Fondo de Investigaciones Santarias (grant code: 97/0035-01, 99/0034-01, and 99/0034-02); Paris: Ministère de l'Emploi et de la Solidarité, Direction Generale de la Sante, UCB-Pharma (France), Aventis (France), Glaxo France, Programme Hospitalier de Recherche Clinique–DRC de Grenoble 2000 #2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble; Pavia: Glaxo-SmithKline Italy, Italian Ministry of University and Scientific and Technological Research, Local University Funding for research 1998 and 1999 (Pavia, Italy); Reykjavik: Icelandic Research Council, Icelandic University Hospital Fund; Tartu: Estonian Science Foundation; Turin: ASL 4 Regione Piemonte (Italy), AO CTO/ICORMA Regione Piemonte (Italy), Italian Ministry of University and Scientific and Technological Research; GlaxoSmithKline Italy; Umeå: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences and Allergy Research, Swedish Asthma and Allergy Foundation, Swedish Cancer and Allergy Foundation; Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences and Allergy Research, Swedish Asthma and Allergy Foundation, Swedish Cancer and Allergy Foundation; Verona: University of Verona; Italian Ministry of University and Scientific and Technological Research; GlaxoSmithKline Italy.Disclosure of potential conflict of interest: A. Soon has received grant support from the Estonian Science Foundation. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(06)01363-7

doi: 10.1016/j.jaci.2006.04.060

The Journal of Allergy and Clinical Immunology
Volume 118, Issue 3 , Pages 682-690 , September 2006